Transparency Market Research Report Added "Alzheimers Disease Therapeutics and Diagnostics Market" to its database.
Albany, NY -- (SBWIRE) -- 12/06/2016 -- As per a new research study by Transparency market Research (TMR), the global market for Alzheimer's disease therapeutics and diagnostics is likely to exhibit phenomenal growth in the next few years. The report, titled "Alzheimers Disease Therapeutics and Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016–2024," presents an all-inclusive assessment of this market on the basis of driving factors, limitations, prominent trends, challenges, opportunities, and its growth potential.
According to the study, the increasing base of geriatric population is the key factor behind the growth of the worldwide Alzheimer's disease therapeutics and diagnostics market. The technical advancements in the field of Alzheimer's therapeutics and diagnostics are also projected to propel this market significantly in the coming years.
Read Full Report: http://www.transparencymarketresearch.com/alzheimers-disease-therapeutics-diagnostics-market.html
In this report, the global Alzheimer's disease therapeutics and diagnostics market has been analyzed on the basis of the diagnostic procedure, therapeutics, imaging technology, and the geography. By therapeutics, the market has been classified into biomarkers, NMDA receptor antagonists, and cholinesterase inhibitors. On the basis of the diagnostic procedure, the market has been categorized into blood tests and brain imaging. Based on the imaging technology, the market has been segmented into functional imaging, structural imaging, and molecular imaging in this research study.
On the geographical front, the global market for Alzheimer's disease therapeutics and diagnostics boasts of a presence across North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. The upswing in the number of Alzheimer's cases, fueled specifically by the growing base of the geriatric population, is reflecting impressively on the North America Alzheimer's disease therapeutics and diagnostics market. The continuous technological advancements in the field of Alzheimer's therapeutics in the region are also boosting this market significantly.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14675
On similar lines, Asia Pacific is also observing a considerable rise in its market for Alzheimer's disease therapeutics and diagnostics. The unmet medical needs in this region are providing lucrative growth opportunities to market players, states the research report.
The research study has also evaluated the competitive landscape of the worldwide market for Alzheimer's disease therapeutics and diagnostics by reviewing the profiles of the leading participants operational in this market. Analysts have thoroughly studied the historical performance and the future prospects of each of the market players in order to define the prevalent market hierarchy. The key market players are focusing aggressively on mergers and acquisitions, joint ventures, partnerships, and agreements to strengthen their businesses, states the market report.
Some of the prominent enterprises functioning in the worldwide Alzheimer's disease therapeutics and diagnostics market are AbbVie Inc., Allergan Plc, AC Immune SA, Amarantus Bioscience Holdings, Avid Radiopharmaceuticals, Anavex LifeSciences, Axon Neuroscience, Daiichi Sankyo Co., Axovant Sciences, Eli Lilly, GE Healthcare, F. Hoffmann-La Roche AG, and Janssen Pharmaceuticals.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453